Jennifer Swainson, MD
- 2Articles
- 24.4KReads1
- 2020Active
- 1Collaborators
- 8Citations2
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
About
Jennifer Swainson, MD, has published research on the use of sublingual ketamine as a treatment option for major depressive disorder (MDD). Her work, appearing in Psychiatrist.com in 2020, explores the accessibility and clinical application of ketamine therapies for depression. She has collaborated with co-author Atul Khullar on these studies.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
